Skip to Main Content

Paper Details

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Hepatology
63
2011
HCV, HCV2, Hb, ITPA, ITPA polymorphisms, ITPA variants, ITPase, ITPase deficiency, Inosine, Inosine triphosphatase, PEG, PEG-IFN-2b, Patients, RBV, anemia, hemoglobin, hemolytic anemia, hepatitis, hepatitis C virus, inosine, inosine triphosphatase, inosine triphosphatase (ITPA) gene, inosine triphosphatase (ITPase) deficiency, patients, pegylated interferon alfa-2b, ribavirin, rs1127354, rs7270101

Datasets